Efficacy And Safety Of A New Clobetasol Propionate 0.05% Foam In Alopecia Areata: A Randomized, Double-Blind Placebo-Controlled Trial

    Antonellá Tosti, Matilde Iorizzo, Gian Luca Botta, Massimo Milani
    TLDR The new clobetasol propionate foam is effective and safe for treating alopecia areata.
    The study evaluated the efficacy, safety, and tolerability of a new clobetasol propionate 0.05% foam (CF) in treating moderate to severe alopecia areata (AA) in a 24-week randomized, double-blind, placebo-controlled trial involving 34 patients. Results showed that 89% of CF-treated sites experienced greater hair regrowth compared to 11% of placebo-treated sites. The hair regrowth score (RGS) was significantly higher in CF-treated sites (1.2 ± 1.6) than in placebo-treated sites (0.4 ± 0.8). By the end of the trial, 47% of CF-treated patients had a RGS of 2 or higher, indicating more than 25% hair regrowth. The treatment was well-tolerated with minimal side effects, such as folliculitis in two patients, and no significant changes in cortisol and ACTH levels. The study concluded that the new clobetasol propionate foam is an effective, safe, and well-tolerated treatment for AA with good patient compliance.
    Discuss this study in the Community →

    Research cited in this study

    5 / 5 results

    Related Community Posts Join

    6 / 57 results

      community any news about DUPA (Diffuse unpatterned alopecia)?

      in Research/Science  8 upvotes 2 years ago
      The conversation discusses diffuse unpatterned alopecia (DUPA) and its possible causes, including sensitivity to DHT, not being androgenic alopecia, being diffuse alopecia areata, or hormonal issues. Treatments mentioned include topical melatonin, Clobetasol Propionate for alopecia areata, and the lack of results from using finasteride, dutasteride, and minoxidil.
      [object Object]
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      in Research  828 upvotes 5 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community 10 months CB and Oral Minoxidil

      in Progress Pictures  111 upvotes 9 months ago
      A person with Alopecia Areata on their beard is using CB-03-01 and oral minoxidil for treatment. Some users question the effectiveness of CB-03-01 for beard hair, suggesting that minoxidil alone may be responsible for any observed hair growth.

      community Lost density 60% all over scalp in 120 days (4months)

      in Update  10 upvotes 7 months ago
      A user lost 60% hair density in 4 months, started finasteride and microneedling, and has greasy, flaky, yellowish scalp. They are awaiting biopsy results, and another user suggested trying ketoconazole shampoo.

      community My experience and a discourse on “DUPA”

      in Chat  46 upvotes 2 years ago
      How diffuse unpatterned alopecia (DUPA) is not an invitation to self-diagnose oneself with aggressive AGA and that seeking a specialized dermatologist may help people experiencing hair loss. Treatment options discussed include topical clobetasol propionate, oral minoxidil, and discontinuing finasteride.

      community The Worst Hair Loss Condition You (MAY) have: LPP

      in Research/Science  43 upvotes 4 months ago
      Lichen Planopilaris (LPP) is an autoimmune condition causing permanent hair loss and fibrosis, often misdiagnosed. Treatments include pioglitazone, topical corticosteroids, anti-inflammatory medication, and Jak inhibitors.

    Related Research

    2 / 2 results